Market Overview:
The global loratadine API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic rhinitis and asthma, increasing demand for over-the-counter (OTC) drugs, and growing awareness about the benefits of loratadine therapy. Based on type, the global loratadine API market is segmented into USP standards grade, EP standards grade, pharmaceutical standards grade, and others. The USP standards grade segment is expected to account for the largest share of the global loratadine API market in 2018. This segment is also projected to grow at a CAGR of 5.7% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to rising demand for high-quality APIs globally. Based on application, the global loratadine API market is divided into Loratadine Tablet, Loratadine Capsules Syrup,, Dry Suspension,. The Loritabte tablet application segment accounted for majority share of revenue generated by applications in 2017 and it will continue its dominance throughout forecast period owing continuous product launches with better efficacy profiles by various manufacturers across different geographies . However , capsules are anticipated witness highest CAGR due their advantages like longer shelf life , easeof handling etc .
Product Definition:
Loratadine API is an antihistamine drug used to treat allergies. It works by blocking histamine receptors, which reduces inflammation and the symptoms of allergy. Loratadine API is important for the development of new allergy medications, as it is one of the most effective antihistamines available.
USP Standards Grade:
USP stands for United States Pharmacopeia. It is a set of standards developed by the U.S. government for the preparation of pharmaceutical drugs and medical devices, which are used across the world to ensure consistent quality products and practices in terms of manufacturing processes, ingredients, packaging & labeling as well as storage & shipment conditions.
EP Standards Grade:
EP standards grade is the standard reference for loratadine. It is a specification that defines the quality and purity of active pharmaceutical ingredients (APIs). Loratadine manufactured by different companies may have slight differences in their chemical structures; however, they should meet EP standards to be sold as “loratadine”.
EP standards grade can also be used for other APIs such as caffeine, paracetamol, digoxin.
Application Insights:
On the basis of application, the global loratadine API market has been segmented into loratadine tablet, loratadine capsules, Loratadinenetwork syrup, dry suspension and others. The tablets were estimated to be the largest revenue-generating segment in 2017. This is due to extensive usage as an anti-allergy agent for preventing and treating allergic rhinitis symptoms such as nasal congestion and sneezing.
The growing prevalence of allergies across the globe is expected to boost product demand over the forecast period. According to Allergy UK¢â‚¬â„¢s 2018/19 allergy statistics release, around 40 million people in Europe suffer from some form of allergy annually; out of which 15 million have moderate or severe asthma symptoms that require medical attention immediately after exposure to an allergen.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of generic drug manufacturers and high adoption rate for new generation drugs are some factors responsible for its largest share. Furthermore, increasing demand for antihistamines due to growing allergic conditions is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan (CIKD). Moreover, an increase in consumer awareness regarding available treatment options will fuel growth during the forecast period. Increasing prevalence of respiratory allergies among children coupled with rising spending capacity at domestic level will further propel this regional market over next eight years. Loratadine API Manufacturers: Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr Reddy's Laboratories Ltd., Avantor Performance Materials Inc.
Growth Factors:
- Increasing prevalence of allergic rhinitis and other respiratory allergies
- Growing demand for over-the-counter medications for the treatment of allergies
- Rising awareness about the benefits of loratadine API in the management of respiratory allergies
- Technological advancements in loratadine API manufacturing process
- Expansion of distribution channels for marketing and selling loratadine API products
Scope Of The Report
Report Attributes
Report Details
Report Title
Loratadine API Market Research Report
By Type
USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others
By Application
Loratadine Tablet, Loratadine Capsules, Loratadine Syrup, Dry Suspension, Others
By Companies
Merck Group, Cadila Pharmaceuticals, Morepen, Ultratech India Limited, Vasudha Pharma Chem, Hetero Drugs Ltd, Mylan, Changzhou Yabang, Shaanxi Hanjiang, Inke, S.A., Argon Drugs, Shenzhen Haibin Pharmaceutical, Shenzhen Salubris Pharmaceuticals, Changzhou Fangyuan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Loratadine API Market Report Segments:
The global Loratadine API market is segmented on the basis of:
Types
USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Loratadine Tablet, Loratadine Capsules, Loratadine Syrup, Dry Suspension, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck Group
- Cadila Pharmaceuticals
- Morepen
- Ultratech India Limited
- Vasudha Pharma Chem
- Hetero Drugs Ltd
- Mylan
- Changzhou Yabang
- Shaanxi Hanjiang
- Inke, S.A.
- Argon Drugs
- Shenzhen Haibin Pharmaceutical
- Shenzhen Salubris Pharmaceuticals
- Changzhou Fangyuan Pharmaceutical
Highlights of The Loratadine API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- USP Standards Grade
- EP Standards Grade
- Pharmaceutical Standards Grade
- Others
- By Application:
- Loratadine Tablet
- Loratadine Capsules
- Loratadine Syrup
- Dry Suspension
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Loratadine API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Loratadine API is a medication used to treat allergies. It works by blocking the release of histamine, which is responsible for allergic reactions.
Some of the major companies in the loratadine api market are Merck Group, Cadila Pharmaceuticals, Morepen, Ultratech India Limited, Vasudha Pharma Chem, Hetero Drugs Ltd, Mylan, Changzhou Yabang, Shaanxi Hanjiang, Inke, S.A., Argon Drugs, Shenzhen Haibin Pharmaceutical, Shenzhen Salubris Pharmaceuticals, Changzhou Fangyuan Pharmaceutical.
The loratadine api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Loratadine API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Loratadine API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Loratadine API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Loratadine API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Loratadine API Market Size & Forecast, 2018-2028
4.5.1 Loratadine API Market Size and Y-o-Y Growth
4.5.2 Loratadine API Market Absolute $ Opportunity
Chapter 5 Global Loratadine API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Loratadine API Market Size Forecast by Type
5.2.1 USP Standards Grade
5.2.2 EP Standards Grade
5.2.3 Pharmaceutical Standards Grade
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Loratadine API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Loratadine API Market Size Forecast by Applications
6.2.1 Loratadine Tablet
6.2.2 Loratadine Capsules
6.2.3 Loratadine Syrup
6.2.4 Dry Suspension
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Loratadine API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Loratadine API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Loratadine API Analysis and Forecast
9.1 Introduction
9.2 North America Loratadine API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Loratadine API Market Size Forecast by Type
9.6.1 USP Standards Grade
9.6.2 EP Standards Grade
9.6.3 Pharmaceutical Standards Grade
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Loratadine API Market Size Forecast by Applications
9.10.1 Loratadine Tablet
9.10.2 Loratadine Capsules
9.10.3 Loratadine Syrup
9.10.4 Dry Suspension
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Loratadine API Analysis and Forecast
10.1 Introduction
10.2 Europe Loratadine API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Loratadine API Market Size Forecast by Type
10.6.1 USP Standards Grade
10.6.2 EP Standards Grade
10.6.3 Pharmaceutical Standards Grade
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Loratadine API Market Size Forecast by Applications
10.10.1 Loratadine Tablet
10.10.2 Loratadine Capsules
10.10.3 Loratadine Syrup
10.10.4 Dry Suspension
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Loratadine API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Loratadine API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Loratadine API Market Size Forecast by Type
11.6.1 USP Standards Grade
11.6.2 EP Standards Grade
11.6.3 Pharmaceutical Standards Grade
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Loratadine API Market Size Forecast by Applications
11.10.1 Loratadine Tablet
11.10.2 Loratadine Capsules
11.10.3 Loratadine Syrup
11.10.4 Dry Suspension
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Loratadine API Analysis and Forecast
12.1 Introduction
12.2 Latin America Loratadine API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Loratadine API Market Size Forecast by Type
12.6.1 USP Standards Grade
12.6.2 EP Standards Grade
12.6.3 Pharmaceutical Standards Grade
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Loratadine API Market Size Forecast by Applications
12.10.1 Loratadine Tablet
12.10.2 Loratadine Capsules
12.10.3 Loratadine Syrup
12.10.4 Dry Suspension
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Loratadine API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Loratadine API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Loratadine API Market Size Forecast by Type
13.6.1 USP Standards Grade
13.6.2 EP Standards Grade
13.6.3 Pharmaceutical Standards Grade
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Loratadine API Market Size Forecast by Applications
13.10.1 Loratadine Tablet
13.10.2 Loratadine Capsules
13.10.3 Loratadine Syrup
13.10.4 Dry Suspension
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Loratadine API Market: Competitive Dashboard
14.2 Global Loratadine API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck Group
14.3.2 Cadila Pharmaceuticals
14.3.3 Morepen
14.3.4 Ultratech India Limited
14.3.5 Vasudha Pharma Chem
14.3.6 Hetero Drugs Ltd
14.3.7 Mylan
14.3.8 Changzhou Yabang
14.3.9 Shaanxi Hanjiang
14.3.10 Inke, S.A.
14.3.11 Argon Drugs
14.3.12 Shenzhen Haibin Pharmaceutical
14.3.13 Shenzhen Salubris Pharmaceuticals
14.3.14 Changzhou Fangyuan Pharmaceutical
